- Compound
- CJC-1295 with DAC, tetrasubstituted GRF(1-29) plus an albumin-binding group
- Backbone
- Modified GRF 1-29: D-Ala at position 2, Gln at 8, Ala at 15, Leu at 27
- The DAC group
- A maleimidopropionyl moiety at Lys30 that forms a covalent bond with circulating albumin
- Residues
- 30, one more than the no-DAC form
- Receptor in the literature
- The GHRH receptor on the anterior pituitary
- Note on CAS numbers
- Vendor catalogues apply CAS 863288-34-0 to both the DAC and no-DAC forms. The two are different molecules; check the stated residue count and the presence of the Lys30 group
- Not the same as
- CJC-1295 No DAC, the 29-residue backbone without the albumin-binding group
- Vial sizes
- 5 mg, 10 mg
- Purity, lot FLL-0629
- 99.46% by HPLC
- Measured content, 5 mg vial
- 6.27 mg by HPLC assay
- Endotoxin, lot FLL-0629
- 1.00 EU/mg against a 70.00 EU/mg limit
- Storage
- −20 °C, sealed, protected from light
- Availability
- CJC-1295 DAC for sale online in 5 mg and 10 mg vials. Ships within the United States.
- Intended use
- Laboratory research only. Not for human or veterinary use.